Home » Covidien, Massimo Extend Royalty Deal for Three Years
Covidien, Massimo Extend Royalty Deal for Three Years
Medical device and drug maker Covidien PLC said Monday it extended a royalty agreement with medical technology company Masimo Corp. for its pulse oximetry products — devices that monitor oxygen in the bloodstream — sold in the United States.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May